SILK Company Profile and Key Details

Q: Who are the executives of SILK?

Dr. Sumaira MacDonaldExecutive Medical DirectorMr. Richard M. RuedyExecutive Vice President of Clinical, Regulatory Affairs & Quality AssuranceMr. Matthew McCarthyVice President of MarketingMs. Erica J. RogersPres, Chief Executive Officer & DirectorMs. Tammy LeitsingerCompliance Officer & Vice President of Medical AffairsMr. Kevin J. BallingerChief Legal & Corporation Sec.Mr. Andrew S. DavisChief Commercial OfficerMs. Mhairi L. JonesChief Accounting Officer & Vice President of Fin.Lynn LewisInvestors Relations OfficerMr. Kevin M. KlemzEVice President, Chief Legal Officer & Sec.Mr. Lucas W. BuchananChief Financial Officer & Chief Operating OfficerMs. Alison HighlanderVice President of HRDr. Sumaira MacDonald M.D., Ph.D.Executive Medical Director

NASDAQ : SILK

Silk Road Medical

$27.49

-0.01-0.04%

At Close 4:00 PM

Not Actively Trading

52.34

B-ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Silk Road Medical, Inc (SILK) stock declined over -0.04%, trading at $27.49 on NASDAQ, down from the previous close of $27.50. The stock opened at $27.49, fluctuating between $27.49 and $27.50 in the recent session.

Stock Snapshot

27.5

Prev. Close

1.12B

Market Cap

27.49

Day Low

-18.958620689655174

P/E Ratio

-1.45

EPS (TTM)

-0.86

Cash Flow per Share

27.49

Open

40.63M

Number of Shares

27.5

Day High

92.61%

Free Float in %

3.87

Book Value

2.31M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 26, 2024	27.49	27.49	27.49	27.49	0
Sep 25, 2024	27.49	27.49	27.49	27.49	0
Sep 24, 2024	27.49	27.49	27.49	27.49	0
Sep 23, 2024	27.49	27.49	27.49	27.49	0
Sep 20, 2024	27.49	27.49	27.49	27.49	0
Sep 19, 2024	27.49	27.49	27.49	27.49	0
Sep 18, 2024	27.49	27.49	27.49	27.49	0
Sep 17, 2024	27.49	27.49	27.49	27.49	0
Sep 16, 2024	27.49	27.51	27.49	27.49	2.31M
Sep 13, 2024	27.48	27.50	27.48	27.50	5.77M
Sep 12, 2024	27.21	27.29	27.18	27.28	676.54K
Sep 11, 2024	27.15	27.26	27.12	27.24	803.03K
Sep 10, 2024	27.10	27.19	27.07	27.19	518.8K
Sep 09, 2024	27.07	27.11	27.02	27.08	947.6K
Sep 06, 2024	27.09	27.10	27.00	27.02	1.42M
Sep 05, 2024	27.10	27.12	27.01	27.02	1.46M
Sep 04, 2024	27.17	27.17	27.03	27.09	1.59M
Sep 03, 2024	27.12	27.16	27.06	27.16	1.28M
Aug 30, 2024	27.10	27.13	27.08	27.11	845.34K
Aug 29, 2024	27.08	27.12	27.08	27.08	836.6K

Contact Details

Sunnyvale, CA 94089

United States

https://silkroadmed.com 408 720 9002

About Company

Silk Road Medical, Inc. operates as an American medical device company, focusing on innovative solutions for carotid artery disease. The firm's product portfolio is specifically engineered to support transcarotid artery revascularization (TCAR) procedures. Among its key offerings is the ENROUTE Transcarotid Neuroprotection System, designed to directly access the common carotid artery and initiate a temporary reversal of blood flow. The company also provides the ENROUTE Transcarotid Stent System, a distinctive stent characterized by its self-expanding and self-tapering capabilities. For streamlined initial entry to the common carotid artery, Silk Road Medical offers the ENHANCE Transcarotid Peripheral Access Kit. Additionally, the ENROUTE 0.014 Guidewire plays a crucial role in navigating and crossing target lesions, enabling the precise delivery of other interventional devices. Founded in 2007, Silk Road Medical, Inc. maintains its primary corporate offices in Sunnyvale, California.

Stock Peers

BRKRP

-6.51-1.63%

Bruker Corporation$393.06 SWAV

-0.08-0.02%

ShockWave Medical, Inc.$334.75 UFPT

0.1+0.04%

UFP Technologies, Inc.$277.99 MASI

Masimo Corporation$179.95 ALGN

2.18+1.45%

Align Technology, Inc.$153.00 PODD

5.84+4.43%

Insulet Corp.$137.80 IRTC

3.29+2.95%

iRhythm Technologies, Inc.$114.72 TMDX

3.68+4.48%

TransMedics Group, Inc.$85.86 DXCM

1.65+1.99%

DexCom, Inc.$84.68 IRMD

0.31+0.38%

IRadimed Corporation$82.53

Company Overview

Silk Road Medical, Inc (NASDAQ:SILK) closed at $27.49 USD, losing -$0.01 (-0.04%) from the previous close of $27.50. The stock is currently trading near its 52-week high $6.08 and $27.51. With a market capitalization of about $1.12 billion, Silk Road Medical, Inc is classified as a small-cap and shows higher-than-market volatility (beta ~1.54). Key stats such as the average daily volume over the past year has been around 2.06 million shares, in line with its 52-week average. Headquartered in Sunnyvale, CA, Silk Road Medical, Inc operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Charles S. McKhann, the company employs approximately 474 people and listed since April 04, 2019. Silk Road Medical, Inc. operates as an American medical device company, focusing on innovative solutions for carotid artery disease.

Technical Performance

Short-term trend indicators are bearishly aligned (SMA20 1.2%, SMA50 1.43%, SMA200 38.46%). The stock’s 14-day RSI is 72.04 (overbought), while the ATR of 0.12 points to tighter daily ranges. The stock remains hovering near 52-week lows, trading -0.07% below its high and over 352.14% above its low.

Valuation Metrics

Silk Road Medical, Inc trades at a P/E ratio of -19.09, slightly below the S&P 500 average, with a price-to-sales ratio of 6.31 and a price-to-book ratio of 7.06 trading at moderately above to book value. The P/FCF stands at -33.32, also below market averages.

Dividend & Fair Value

Silk Road Medical, Inc last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $52.54. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

Silk Road Medical, Inc generated EPS of -$1.44 over the past year. Five-year average earnings growth is -3.21%. Wall Street analysts project EPS growth of 1.6% annually over the next five years. The latest quarter delivered EPS of -$0.42. The next quarter is forecast at -$0.44. Next year's EPS is expected at $2.57. Silk Road Medical, Inc earnings surprise history is a mixed track record. The quarter that ended August 07, 2024, missed forecasts by 10.53%. The prior quarter beat by -10.0%. Over the last six quarters, Apple has recorded several small beats. These include 10.26% in May 09, 2023.

Shareholding & Insider Activity

Silk Road Medical, Inc has 40.63 million shares outstanding. The public float is 37.63 million shares, elevated short interest at 7.87% of float. This equals 3.15 million shares. The short ratio is 2.48 days. Institutional investors hold 101.68% of the float. Insiders own 4.15%. Buchanan Lucas W. holds 500.92 thousand shares, Davis Andrew S. has 289.71 thousand shares and Rogers Erica J. has 269.64 thousand shares.

Financial & Profitability Overview

Over the trailing twelve months, Silk Road Medical generated $177.13M in revenue, or $4.56 per share. Gross margin was 71.75%, operating margin -33.46%, and net profit margin -31.47%. Returns are negative, with ROA at -21.01% and ROE at -36.88%.
On valuation metrics, Silk Road Medical trades at a P/E of -19.09, P/S of 6.31 and P/B of 7.06. The current ratio is 7.95 and quick ratio is 6.97. Operationally, the company’s inventory turnover is 1.68 and cash conversion cycle is 225.06 days. Debt-to-equity is 0.56, supported by a cash flow-to-debt ratio of -0.38.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2023, Silk Road Medical posted revenue of $177.13M, down slightly from $138.64M in the prior quarter. Gross profit was $127.09M (margin 71.75%). Operating income was - $59.27M (margin -33.5%). Net income was- $55.74M (EPS - $1.44).
The company ended the quarter with $181.47M in cash and short-term investments, a total debt of $84.63M, and net debt of $64.42M. Total assets were $265.31M, with equity of $151.15M. Financials further reflected weakness, with operating cash flow of - $32.01M, free cash flow of - $33.52M, and capital expenditures of - $1.51M.

Price Forecast & Outlook

Our AI price prediction model suggests that Silk Road Medical, Inc stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -0.04%, with price expected at $27.48 by October 10, 2024, within a range of $24.79 to $29.80 3-Month Outlook: Projected fall of -57.69%, reaching $11.63 by December 16, 2024, with a range of $10.23 to $12.56. 1-Year Outlook: Projected loss of -55.91%, with price at $12.12 by September 17, 2025, within a range of $9.28 to $16.47.

Key Takeaways

Silk Road Medical, Inc (NASDAQ:SILK) shares are up 124.04% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Silk Road Medical, Inc trading at a premium to the broader market with a P/E of -19.09. Analyst sentiment is mixed, with the majority of ratings in Hold territory and a mean price target of $42.50, suggesting 54.6% upside. Our AI forecast model points to short-term weakness (-0.04% over two weeks), a medium-term fall (-57.69% over three months), and a longer-term loss (-55.91% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current Silk Road Medical, Inc (SILK) stock price?

Silk Road Medical, Inc (NASDAQ: SILK) stock price is $27.49 in the last trading session. During the trading session, SILK stock reached the peak price of $27.50 while $27.49 was the lowest point it dropped to. The percentage change in SILK stock occurred in the recent session was -0.04% while the dollar amount for the price change in SILK stock was - $0.01.

SILK's industry and sector of operation?

The NASDAQ listed SILK is part of Medical - Devices industry that operates in the broader Healthcare sector. Silk Road Medical, Inc designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of SILK?

Dr. Sumaira MacDonald
Executive Medical Director
Mr. Richard M. Ruedy
Executive Vice President of Clinical, Regulatory Affairs & Quality Assurance
Mr. Matthew McCarthy
Vice President of Marketing
Ms. Erica J. Rogers
Pres, Chief Executive Officer & Director
Ms. Tammy Leitsinger
Compliance Officer & Vice President of Medical Affairs
Mr. Kevin J. Ballinger
Chief Legal & Corporation Sec.
Mr. Andrew S. Davis
Chief Commercial Officer
Ms. Mhairi L. Jones
Chief Accounting Officer & Vice President of Fin.
Lynn Lewis
Investors Relations Officer
Mr. Kevin M. Klemz
EVice President, Chief Legal Officer & Sec.
Mr. Lucas W. Buchanan
Chief Financial Officer & Chief Operating Officer
Ms. Alison Highlander
Vice President of HR
Dr. Sumaira MacDonald M.D., Ph.D.
Executive Medical Director

How SILK did perform over past 52-week?

SILK's closing price is 352.14% higher than its 52-week low of $6.08 where as its distance from 52-week high of $27.51 is -0.07%.

How many employees does SILK have?

Number of SILK employees currently stands at 474.

Link for SILK official website?

Official Website of SILK is: https://silkroadmed.com

How do I contact SILK?

SILK could be contacted at phone 408 720 9002 and can also be accessed through its website. SILK operates from 1213 Innsbruck Drive, Sunnyvale, CA 94089, United States.

How many shares of SILK are traded daily?

SILK stock volume for the day was 2.31M shares. The average number of SILK shares traded daily for last 3 months was 2.06M.

What is the market cap of SILK currently?

The market value of SILK currently stands at $1.12B with its latest stock price at $27.49 and 40.63M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	474
Beta	1.54
Sales or Revenue	$177.13M
5Y Sales Change%	2.793%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Devices

SILK Company Profile and Key Details

Silk Road Medical

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Earnings & Analyst Outlook

Shareholding & Insider Activity

Dividend & Fair Value

Financial & Profitability Overview

Quarterly Financial Highlights

Key Takeaways

Price Forecast & Outlook

Company Overview

Valuation Metrics